COPYRIGHT© Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

COPYRIGHT© 2018  吉林紫鑫药业股份有限公司

Jilin Zixin Pharmaceutical Co., Ltd.

Page view
The company and all members of the board of directors guarantee that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.
 
     Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as “the company”) applied for the non-public offering of shares, and the company applied to the Shenzhen Stock Exchange for trading. The company's shares were suspended from the opening on August 21, 2014. On September 3, 2014, the company held the 18th meeting of the fifth board of directors, reviewed and approved the relevant proposal on this non-public offering of shares, and published the above announcement on the company's designated media on September 4, 2014. Securities Times, China Securities Journal, Shanghai Securities News, Securities Daily and www.cninfo.com.cn.
 
     According to the relevant regulations, after the company applied for, the company's stock (stock short name: Zixin Pharmaceutical, stock code: 002118) resumed trading on September 4, 2014.
 
  
 
 
 
Special announcement
 
Jilin Zixin Pharmaceutical Co., Ltd.
 
Board of Directors
 
                                    September 4, 2014